Ter Meulen Jan Henrik

Avg. Two Year Performance

No purchase track record

20% Avg. Sale Return

9% Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	9%	4%	(31%)	35%	20%
Sale Success Rate	2 of 3	1 of 3	0 of 3	2 of 3	1 of 3

Immune Design Corp.

Drugs » Biotechnology

Chief Scientific Officer:

Holdings: 0 shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--